Table 2.
List of Compounds Discovered from the Screening of 5 Libraries (8284 compounds) and Whether the Compound or Its Mechanistic Class Was Previously Known to Disassemble the PNC
| Library | Compound | Previously Discovered | Mechanistic Class | Mechanistic Class Known to Reduce PNC |
|---|---|---|---|---|
| LOPAC | (S)-(+)-camptothecin | [10] | Topo I inhibitor | Yes |
| 7-Chloro-4-hydroxy-2-phenyl-1,8-naphthyridine | No | Adenosine receptor antagonist | No | |
| Diphenyleneiodonium chloride | No | Nitric oxide synthase inhibitor | No | |
| Ellipticine | [10] | Intercalator | Yes | |
| Etoposide | [10] | Topo II inhibitor | Yes | |
| Genistein | Yes (our unpublished data) | Topo II inhibitor at high doses | Yes | |
| Mitoxantrone | [10] | Intercalator | Yes | |
| Methotrexate | [10] | Inhibits RNA synthesis | Yes | |
| Quinacrine dihydrochloride | No | Intercalator | Yes | |
| NCGC in house | Acriflavinium | Yes (our unpublished data) | Intercalator | Yes |
| 9-Aminoacridine | Yes (our unpublished data) | Intercalator | Yes | |
| Daunorubicin | [10] | DNA intercalator and Topo II inhibitor | Yes | |
| 3,6-Diaminoacridine | Yes (our unpublished data) | Intercalator | Yes | |
| Doxorubicin | [10] | DNA intercalator and Topo II inhibitor | Yes | |
| Mofetil | No | Nucleoside analog | Yes | |
| Topotecan | [10] | Topo I inhibitor | Yes | |
| Zidovudine | No | Nucleoside analog | Yes | |
| Tocris/Timtec | Actinomycin D | [10] | DNA intercalator and Topo II inhibitor | Yes |
| Camptothecin | [10] | Topo I inhibitor | Yes | |
| Chelidonine | No | Tubilin inhibitor | No | |
| Prestwick | Camptothecin | [10] | Topo I inhibitor | Yes |
| Daunorubicin | [10] | DNA intercalator and Topo II inhibitor | Yes | |
| Doxorubicin | [10] | DNA intercalator and Topo II inhibitor | Yes | |
| Biomol | Actinomycin D | [10] | DNA intercalator and Topo II inhibitor | Yes |
| (S)-(+)-Camptothecin | [10] | Topo I inhibitor | Yes | |
| Diphenyleneiodonium chloride | No | Nitric oxide synthase inhibitor | No | |
| Hydroxy-camptothecin | No | Topo I inhibitor | Yes |
LOPAC, Library of Pharmacologically Active Compounds; NCGC, National Institutes of Health Chemical Genomics Center; PNC, perinucleolar compartment.